Researchers at Keele University have published the first investigation into the variation in the chemical makeup of calcifications caused by prostate cancer, in the hope of identifying new markers to ...

A novel theranostic approach that targets RET -- a newly identified biomarker for neuroendocrine prostate cancer enables high ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

The breakthrough at Columbia University lays the groundwork for future clinical studies aimed at developing new treatments.

A new screening tool for prostate cancer could help reduce the number of deaths from the disease, experts have said. Researchers have developed a new algorithm estimating a person’s risk of developing ...

Targeted cancer therapies are an expanding field of effective therapeutic approaches. While previous chemotherapy agents indiscriminately killed rapidly proliferating cells, newer “precision medicine” ...